FOCUS-Patient groups push back against Gilead's pricey HIV prevention treatment
August 07, 2019 at 06:00 AM EDT
Gilead Sciences Inc hopes to soon introduce a pricey new pill to prevent HIV in people at risk of contracting the infection, but the drugmaker faces opposition from an unusual source: patient advocates.